NCT04889716 2026-03-18CAR-T Followed by Bispecific AntibodiesAbramson Cancer Center at Penn MedicinePhase 2 Recruiting42 enrolled
NCT07326371 2026-01-08Glofitamab Combined With CAR-T Therapy in R/R DLBCLRuijin HospitalPhase 2 Not yet recruiting24 enrolled